Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rEMS and PRP for Deep Retinal Capillary Ischemia
NCT04242719Completed
- Sponsor
- Ankara Üniversitesi Teknokent
- Start
- Jan 2018
- Primary completion
- Jan 2019
- Modality
- Hydrogel Systems, Cell Therapies
- Countries
- 1
01
Overview
Open-label trial of autologous platelet rich gel in Deep retinal capillary ischemia (DRCI), sponsored by Ankara Üniversitesi Teknokent. Primary endpoint: Deep retinal capillary vessel density at 1 month. Started Jan 2018; status: completed.
02
Drugs
autologous platelet rich gel
03
Conditions
Deep retinal capillary ischemia (DRCI)
Beyond the preview
Go deeper on NCT04242719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04242719.